✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. NeurologyResearchAgingSafetyMental Health Clinical Summary A large prospective study analyzing data from the UK Biobank and...
Daily Digest: Last 19 Hours: Aging Brains, Adolescent Risk, and the Slow March of Policy Reform — March 04, 2026
A synthesis of 53 recently added cannabis articles — key themes, clinical context, and Dr. Caplan’s take.
West Virginia House approves bill allowing medical cannabis edibles | WV News
WHY IT MATTERS: West Virginia medical cannabis patients who previously had limited delivery options may soon be able to access edible formulations, giving physicians and patients more tools to tailor treatment to individual medical needs. CLINICAL OVERVIEW: West Virginia’s expansion of its medical cannabis program to include edible formulations represents a meaningful step toward improving patient access and treatment flexibility. Edibles offer distinct pharmacokinetic advantages for certain patient populations, particularly those with respiratory conditions who cannot tolerate inhalation, or those requiring longer-duration symptom relief due to the slower onset and extended duration of orally administered cannabinoids.
Study Shows Lifetime Cannabis Use Not Associated with Cognitive Decline or Dementia …
WHY IT MATTERS: Older adults who have used cannabis throughout their lives, or who are considering it now for pain, sleep, or anxiety, can have a more informed conversation with their physician without the assumption that cognitive decline is an inevitable consequence. CLINICAL OVERVIEW: Emerging research from major academic institutions is challenging longstanding assumptions that cannabis use accelerates cognitive aging or increases dementia risk in older populations. The data suggest that lifetime exposure to cannabis, when examined in older adult cohorts, does not appear to correlate with measurable declines in cognitive function or elevated dementia incidence.
Cannabis Use and Brain Aging: What a Major Study Reveals – Born2Invest
WHY IT MATTERS: Patients who use cannabis regularly and are concerned about long-term brain health now have large-scale data to discuss with their physician, though the findings underscore the importance of individualized conversations rather than blanket reassurance or alarm. CLINICAL OVERVIEW: Research drawing on large biobank datasets has examined whether cannabis use is associated with measurable changes in brain aging trajectories. The findings suggest a nuanced picture in which cannabis users may show some initial differences in brain age metrics, but the relationship between cannabis exposure and long-term neurological aging is not straightforwardly harmful or protective.
Study finds no links between cannabis use and cognitive decline or dementia in older people
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchNeurologyAgingSafety Why This Matters Clinicians can now provide more reassurance to older adult patients concerned...
Study finds no links between cannabis use and cognitive decline or dementia in older people
✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchNeurologyAgingSafety Why This Matters This finding is clinically significant because it challenges a common assumption...
Daily Digest: Last 48 Hours: Adolescent Risk, Aging Brains, and the Long Road to Pharmaceutical-Grade Cannabis — March 04, 2026
A synthesis of 53 recently added cannabis articles — key themes, clinical context, and Dr. Caplan’s take.
Daily Digest: Last 24 Hours: Adolescent Risk, Aging Brains, and the Slow March Toward Pharmaceutical-Grade Cannabis — March 04, 2026
Last 24 Hours March 04, 2026 — 41 articles reviewed This cycle’s coverage clustered around two poles of the age spectrum, with a single study in Pediatrics reinforcing that even infrequent adolescent...
Study finds no links between cannabis use and cognitive decline or dementia in older people
WHY IT MATTERS: Older adults who use cannabis for pain, sleep, or anxiety can share this research with their physicians to support more informed, evidence-based conversations about risk rather than assumption-based discouragement. CLINICAL OVERVIEW: Concerns about cannabis use accelerating cognitive decline or contributing to dementia risk in older adults have long influenced clinical conversations, but emerging research is beginning to challenge those assumptions. The biological reality is complex, given that the endocannabinoid system plays a regulatory role in neuroinflammation and neuroprotection, and that older adults are using cannabis for legitimate symptom management at increasing rates.